Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China
The aim was to better understand the clinical characteristics of patients with mucormycosis in western China. We retrospectively investigated the clinical, laboratory, radiological and treatment profiles of mucormycosis patients during a 10-year period (2010–2019). As a result, 59 proven mucormycosi...
Guardado en:
Autores principales: | Junyan Qu, Xijiao Liu, Xiaoju Lv |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a047d29131a94e8d90d6258debe8b85f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
por: F. Yuan, et al.
Publicado: (2021) -
Mucormycosis in Hematologic Malignancies: Clinical Follow-Up and Treatment Results
por: Nagehan Didem Sarı, et al.
Publicado: (2021) -
Rhino-orbito-cerebral Mucormycosis: Pictorial Review
por: Vivek Pai, et al.
Publicado: (2021) -
First reported case of late recurrence of pulmonary mucormycosis in a renal transplant recipient with poorly controlled diabetes mellitus
por: Cheuk Cheung Derek Leung, et al.
Publicado: (2021) -
Inhibition of EGFR Signaling Protects from Mucormycosis
por: Tonya N. Watkins, et al.
Publicado: (2018)